Cargando…

Optimal Management of Hereditary Angioedema: Shared Decision-Making

All patients with hereditary angioedema (HAE) must have access to on-demand therapy to treat attacks and may benefit from prophylactic therapy to reduce the attack frequency. Treatment decisions should be individualized, based on patient preferences and needs. One method for facilitating individuali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerji, Aleena, Anderson, John, Johnston, Douglas T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881782/ https://www.ncbi.nlm.nih.gov/pubmed/33603408 http://dx.doi.org/10.2147/JAA.S284029

Ejemplares similares

Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study
por: Johnston, Douglas T., et al.
Publicado: (2021)

Informed decision‐making in hereditary angioedema prophylaxis
por: Burnette, Autumn Ford
Publicado: (2021)

Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
por: Banerji, Aleena, et al.
Publicado: (2021)

Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain
por: Staller, Kyle, et al.
Publicado: (2022)

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States
por: Riedl, Marc A, et al.
Publicado: (2018)

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
por: Riedl, Marc A., et al.
Publicado: (2020)

The Importance of Shared Decision-Making for Patients with Glioblastoma
por: Musella, Al, et al.
Publicado: (2021)

Teaching Shared Decision Making to Undergraduate Medical Students
por: Tidhar, Meira, et al.
Publicado: (2021)

Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey
por: Banerji, Aleena, et al.
Publicado: (2016)

Improving the Management of Hereditary Angioedema
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2018)

The importance and challenges of shared decision making in older people with multimorbidity
por: Hoffmann, Tammy, et al.
Publicado: (2018)

Diagnostic dilemmas in Alzheimer's disease: Room for shared decision making
por: van der Flier, Wiesje M., et al.
Publicado: (2017)

Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study
por: Lumry, William R., et al.
Publicado: (2020)

Hereditary angioedema
por: Lesser, Helen, et al.
Publicado: (2021)

Hereditary Angioedema
por: Banerjee, Anjali, et al.
Publicado: (2023)

Does hereditary angioedema make COVID-19 worse?
por: Xu, Yingyang, et al.
Publicado: (2020)

Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report
por: Bork, Konrad, et al.
Publicado: (2021)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Perioperative management for patients with hereditary angioedema
por: Williams, Anesu H., et al.
Publicado: (2015)

Management of hereditary angioedema: 2010 Canadian approach
por: Bowen, Tom, et al.
Publicado: (2010)

The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making
por: Wang, Michael, et al.
Publicado: (2022)

Supporting Shared Decision-Making and Home Dialysis in End-Stage Kidney Disease
por: Campbell-Montalvo, Rebecca, et al.
Publicado: (2022)

Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies
por: Busse, Paula J., et al.
Publicado: (2018)

Shared decision‐making for infant feeding and care during the coronavirus disease 2019 pandemic
por: Haiek, Laura N., et al.
Publicado: (2021)

Importance of Shared Decision-Making for Vulnerable Populations: Examples from Postmastectomy Breast Reconstruction
por: Grabinski, Victoria F., et al.
Publicado: (2018)

Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor
por: Jones, Douglas, et al.
Publicado: (2023)

Biomarkers in Hereditary Angioedema
por: Porebski, Grzegorz, et al.
Publicado: (2021)

Hereditary angioedema in women
por: Bouillet, Laurence
Publicado: (2010)

Hereditary Angioedema: Not An Allergy
por: Bhivgade, Sanjay, et al.
Publicado: (2012)

The Pathophysiology of Hereditary Angioedema
por: Zuraw, Bruce L
Publicado: (2010)

Pediatric hereditary angioedema
por: MacGinnitie, Andrew J
Publicado: (2014)

Hereditary angioedema in childhood
por: Ahn, Young Min
Publicado: (2020)

Lanadelumab for hereditary angioedema
Publicado: (2022)

Hereditary angioedema: epidemiology, management, and role of icatibant
por: Ghazi, Aasia, et al.
Publicado: (2013)

Getting (Along) With the Guidelines: Reconciling Patient Autonomy and Quality Improvement Through Shared Decision Making
por: Xu, Yan, et al.
Publicado: (2016)

Clinical records organized and optimized for clinical integration and clinical decision making
por: Vanderbilt, Allison A., et al.
Publicado: (2016)

Canadian hereditary angioedema guideline
por: Betschel, Stephen, et al.
Publicado: (2014)

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
por: Maurer, Marcus, et al.
Publicado: (2022)

Hereditary Angioedema Consensus 2010
por: Bowen, Tom
Publicado: (2010)

Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_arqqopn7qhhsaatjvctkvfs1pe